Back
Y-mAbs Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
YMAB
Y-mAbs Therapeutics
Last Price:
$4.33
Seasonality Move:
-4.07%
7 Day Trial
ALL ACCESS PASS
$
7
Y-mAbs Therapeutics Stock Forecast
-
Is Y-mAbs Therapeutics Stock Undervalued?The current Y-mAbs Therapeutics [YMAB] share price is $4.32. The Score for YMAB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
YMAB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Y-mAbs Therapeutics Stock Go Up Next Year?
Data Unavailable
Y-mAbs Therapeutics Stock Rating
Data Unavailable
Y-mAbs Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ymabs.com
52-Week Data
52-Week High:
16.11
52-Week Low:
3.55
Prediction Charts
Market Cap:
195.7M
Price in USD:
4.32
Volume:
111.8K
Beta:
0.82
Technical Analysis
SMA50:
4.48
SMA100:
4.63
SMA200:
7.49
52-Wk Change:
-65.66%
Stock Predictions
-
Is Y-mAbs Therapeutics stock public?Yes, Y-mAbs Therapeutics is a publicly traded company.
-
What is the Y-mAbs Therapeutics stock quote today?The Y-mAbs Therapeutics stock price is 4.32 USD today.
-
How to buy Y-mAbs Therapeutics stock online?You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-27 | 4.78 | 4.70 | 4.78 | 4.58 |
| Jun-30 | 4.71 | 4.51 | 4.73 | 4.48 |
| Jul-1 | 4.51 | 4.41 | 4.62 | 4.40 |
| Jul-2 | 4.41 | 4.26 | 4.57 | 4.25 |
| Jul-3 | 4.31 | 4.30 | 4.33 | 4.18 |
| Jul-7 | 4.27 | 4.22 | 4.33 | 4.10 |
| Jul-8 | 4.24 | 4.21 | 4.40 | 4.20 |
| Jul-9 | 4.21 | 4.44 | 4.62 | 4.21 |
| Jul-10 | 4.45 | 4.52 | 4.58 | 4.36 |
| Jul-11 | 4.46 | 4.36 | 4.48 | 4.27 |
| Jul-14 | 4.34 | 4.36 | 4.44 | 4.23 |
| Jul-15 | 4.37 | 4.22 | 4.42 | 4.22 |
| Jul-16 | 4.25 | 4.35 | 4.39 | 4.20 |
| Jul-17 | 4.32 | 4.32 | 4.42 | 4.30 |
Y-mAbs Therapeutics Earnings
Data Unavailable
Y-mAbs Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.09 per share.
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.